Logos Global Management LP Mirati Therapeutics, Inc. Call Options Transaction History

Logos Global Management LP

  • $761 Million
  • Q4 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$72.01 - $120.39 $2.4 Million - $4.01 Million
-33,300 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$69.78 - $116.21 $11.6 Million - $19.4 Million
-166,700 Reduced 83.35%
33,300 $2.56 Million
Q4 2019

Feb 14, 2020
BUY
$70.76 - $128.86 $14.2 Million - $25.8 Million
200,000 New
200,000 $25.8 Million

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email